Protalix BioTherapeutics, Inc. today announced the appointment of Mr. Tzvi Palash as the Company’s Chief Operating Officer. Â In this newly created position, Mr. Palash will be responsible for overseeing the Company’s manufacturing activities and implementing the expansion phase of the Company’s facility as it transitions from a research and development organization to a fully-integrated …
